欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	AT/H/1196/004
药品名称	Venlafaxine HCl Sandoz XR 225 mg prolonged-release capsules, hard
活性成分	VENLAFAXINE HYDROCHLORIDE 225.0 mg
剂型	Prolonged-release capsule, hard
上市许可持有人	Sandoz B.V. Veluwezoom 22 1327 AH Almere The Netherlands
参考成员国 - 产品名称	Austria (AT) Venlafaxin Sandoz GmbH 225 mg – Hartkapseln, retardiert
互认成员国 - 产品名称	Portugal (PT) Denmark (DK) Belgium (BE) Venlafaxin Retard Sandoz 225 mg harde capsules met verlengde afgifte Spain (ES) Norway (NO) Germany (DE) Venlafaxin - 1A Pharma 225 mg Hartkapseln, retardiert
许可日期	2017/12/22
最近更新日期	2024/04/29
药物ATC编码	N06AX16 venlafaxine
申请类型	TypeLevel1：[not specified] TypeLevel2：[not specified] TypeLevel3：[not specified] TypeLevel4：[not specified] TypeLevel5：[not specified]
附件文件下载	Final PL \| final PL AT_H_1196_001_004_IB_019 clDate of last change:2023/08/03 Final SPC \| final SmPC AT_H_1196_001_004_IB_019 clDate of last change:2023/08/03 Final Labelling \| final_LAB_AT_H_1196_1197_1198_001_004_R_001Date of last change:2022/11/03 PAR \| AT_H_1196_001-004 PARDate of last change:2021/04/14 PAR Summary \| 190516 NL.H.3961.001-004.DC Venlafaxine HCl Sandoz summary ENDate of last change:2019/08/01 Final Product Information \| common-outer - cleanDate of last change:2018/02/08 Final Product Information \| common-pl - cleanDate of last change:2018/02/08 Final Product Information \| common-spc - cleanDate of last change:2018/02/08
市场状态	Positive